Cargando…

Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce

BACKGROUND: The present study was carried out to evaluate cerebral perfusion in multiple sclerosis (MS) patients with a moderate to severe stage of disease. Some patients underwent hyperbaric oxygen therapy (HBOT) and brain perfusion between before and after that was compared. METHODS: We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh Asl, Mina, Nemati, Reza, Chabi, Negar, Salimipour, Hooman, Nabipour, Iraj, Assadi, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880822/
https://www.ncbi.nlm.nih.gov/pubmed/27229156
http://dx.doi.org/10.1186/s12883-016-0605-4
_version_ 1782433850697187328
author Taghizadeh Asl, Mina
Nemati, Reza
Chabi, Negar
Salimipour, Hooman
Nabipour, Iraj
Assadi, Majid
author_facet Taghizadeh Asl, Mina
Nemati, Reza
Chabi, Negar
Salimipour, Hooman
Nabipour, Iraj
Assadi, Majid
author_sort Taghizadeh Asl, Mina
collection PubMed
description BACKGROUND: The present study was carried out to evaluate cerebral perfusion in multiple sclerosis (MS) patients with a moderate to severe stage of disease. Some patients underwent hyperbaric oxygen therapy (HBOT) and brain perfusion between before and after that was compared. METHODS: We retrospectively reviewed 25 secondary progressive (SP)-MS patients from the hospital database. Neurological disability evaluated by Expanded Disability Status Scale Score (EDSS). Brain perfusion was performed by (99 m) Tc-labeled bicisate (ECD) brain SPECT and the data were compared using statistical parametric mapping (SPM). In total, 16 patients underwent HBOT. Before HBOT and at the end of 20 sessions of oxygen treatment, 99mTc-ECD brain perfusion single photon emission computed tomography (SPECT) was performed again then the results were evaluated and compared. Brain perfusion was performed by (99 m) Tc-labeled bicisate (ECD) brain SPECT and the data were compared using statistical parametric mapping (SPM). RESULTS: A total of 25 SP-MS patients, 14 females (56 %) and 11 males (44 %) with a mean age of 38.92 ± 11.28 years included in the study. The mean disease duration was 8.70 ± 5.30 years. Of the 25 patients, 2 (8 %) had a normal SPECT and 23 (92 %) had abnormal brain perfusion SPECT studies. The study showed a significant association between severity of perfusion impairment with disease duration and also with EDSS (P <0.05). There was a significant improvement in pre- and post-treatment perfusion scans (P <0.05), but this did not demonstrate a significant improvement in the clinical subjective and objective evaluation of patients (P >0.05). CONCLUSIONS: This study depicted decreased cerebral perfusion in SP-MS patients with a moderate to severe disability score and its association with clinical parameters. Because of its accessibility, rather low price, practical ease, and being objective quantitative information, brain perfusion SPECT can be complementing to other diagnostic modalities such as MRI and clinical examinations in disease surveillance and monitoring. The literature on this important issue is extremely scarce, and follow up studies are required to assess these preliminary results.
format Online
Article
Text
id pubmed-4880822
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48808222016-05-27 Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce Taghizadeh Asl, Mina Nemati, Reza Chabi, Negar Salimipour, Hooman Nabipour, Iraj Assadi, Majid BMC Neurol Research Article BACKGROUND: The present study was carried out to evaluate cerebral perfusion in multiple sclerosis (MS) patients with a moderate to severe stage of disease. Some patients underwent hyperbaric oxygen therapy (HBOT) and brain perfusion between before and after that was compared. METHODS: We retrospectively reviewed 25 secondary progressive (SP)-MS patients from the hospital database. Neurological disability evaluated by Expanded Disability Status Scale Score (EDSS). Brain perfusion was performed by (99 m) Tc-labeled bicisate (ECD) brain SPECT and the data were compared using statistical parametric mapping (SPM). In total, 16 patients underwent HBOT. Before HBOT and at the end of 20 sessions of oxygen treatment, 99mTc-ECD brain perfusion single photon emission computed tomography (SPECT) was performed again then the results were evaluated and compared. Brain perfusion was performed by (99 m) Tc-labeled bicisate (ECD) brain SPECT and the data were compared using statistical parametric mapping (SPM). RESULTS: A total of 25 SP-MS patients, 14 females (56 %) and 11 males (44 %) with a mean age of 38.92 ± 11.28 years included in the study. The mean disease duration was 8.70 ± 5.30 years. Of the 25 patients, 2 (8 %) had a normal SPECT and 23 (92 %) had abnormal brain perfusion SPECT studies. The study showed a significant association between severity of perfusion impairment with disease duration and also with EDSS (P <0.05). There was a significant improvement in pre- and post-treatment perfusion scans (P <0.05), but this did not demonstrate a significant improvement in the clinical subjective and objective evaluation of patients (P >0.05). CONCLUSIONS: This study depicted decreased cerebral perfusion in SP-MS patients with a moderate to severe disability score and its association with clinical parameters. Because of its accessibility, rather low price, practical ease, and being objective quantitative information, brain perfusion SPECT can be complementing to other diagnostic modalities such as MRI and clinical examinations in disease surveillance and monitoring. The literature on this important issue is extremely scarce, and follow up studies are required to assess these preliminary results. BioMed Central 2016-05-26 /pmc/articles/PMC4880822/ /pubmed/27229156 http://dx.doi.org/10.1186/s12883-016-0605-4 Text en © Taghizadeh As et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Taghizadeh Asl, Mina
Nemati, Reza
Chabi, Negar
Salimipour, Hooman
Nabipour, Iraj
Assadi, Majid
Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title_full Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title_fullStr Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title_full_unstemmed Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title_short Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
title_sort brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880822/
https://www.ncbi.nlm.nih.gov/pubmed/27229156
http://dx.doi.org/10.1186/s12883-016-0605-4
work_keys_str_mv AT taghizadehaslmina brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce
AT nematireza brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce
AT chabinegar brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce
AT salimipourhooman brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce
AT nabipouriraj brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce
AT assadimajid brainperfusionimagingwithvoxelbasedanalysisinsecondaryprogressivemultiplesclerosispatientswithamoderatetoseverestageofdiseaseaboonfortheworkforce